Current and future treatment for alcoholic‐related liver diseases
Journal of Gastroenterology and Hepatology · 2023
DOI: 10.1111/jgh.16257 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, 2023. Verfasst von Eileen L Yoon und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Hepatitis, Alcoholic, Liver Diseases, Alcoholic, Liver Transplantation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
The socioeconomic burden of alcohol‐related liver disease has been increasing worldwide. Its prevalence is underestimated, and patients with alcohol‐related liver disease are rarely diagnosed in the earlier phase of the disease spectrum. Alcoholic hepatitis is a distinct syndrome with life‐threatening signs of systemic inflammation. In severe alcoholic hepatitis, prednisolone is indicated as the first‐line treatment even with the possibility of various complications. Early liver transplantation can be another option for highly selected patients with a null response to prednisolone. Most importantly, abstinence is the mainstay of long‐term care, but relapse is frequent among patients. Recent findings on the pathogenesis of alcoholic hepatitis have enabled us to discover new therapeutic targets. Preventing hepatic inflammation, reducing oxidative stress, improving gut dysbiosis, and enhancing liver regeneration are the main targets of emerging therapies. Herein, we review the pathogenesis, current treatment, and barriers to successful clinical trials of alcoholic hepatitis. Additionally, clinical trials for alcoholic hepatitis, either ongoing or recently completed, will be briefly introduced.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
- Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul National University College of Medicine and Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea.
ORCID-Profile: Won Kim
Zitieren
APA
Yoon, E. L., & Kim, W. (2023). Current and future treatment for alcoholic‐related liver diseases. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16257
Vancouver
Yoon EL, Kim W. Current and future treatment for alcoholic‐related liver diseases. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16257
BibTeX
@article{Yoon2023,
author = {Yoon, Eileen L and Kim, Won},
title = {Current and future treatment for alcoholic‐related liver diseases},
journal = {Journal of Gastroenterology and Hepatology},
year = {2023},
doi = {10.1111/jgh.16257}
}
EUVIMED